Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking

Soluble dipeptidyl peptidase-4 induces microvascular endothelial dysfunction through proteinase-activated receptor-2 and thromboxane A2 release

(2016) Tania Romacho et al.   JOURNAL OF HYPERTENSION

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus

(2016) Abd A. Tahrani et al.   Nature Reviews Endocrinology

Targeting metabolic disturbance in the diabetic heart

(2015) Jesús Fuentes-Antrás et al.   Cardiovascular Diabetology

Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial

(2015) Hiroki Oe et al.   Cardiovascular Diabetology

Speckle tracking echocardiography in the diagnosis of early left ventricular systolic dysfunction in type II diabetic mice

(2014) Rong-juan Li et al.   BMC Cardiovascular Disorders

Chronic Dipeptidyl Peptidase-4 Inhibition With Sitagliptin Is Associated With Sustained Protection Against Ischemic Left Ventricular Dysfunction in a Pilot Study of Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

(2014) Liam M. McCormick et al.   Circulation-Cardiovascular Imaging

Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms

(2014) Belén Picatoste et al.   PLoS One

Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy

(2013) N Fillmore et al.   BRITISH JOURNAL OF PHARMACOLOGY

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

(2013) Elisa Ramírez et al.   Cardiovascular Diabetology

Cardiac Metabolism in Heart Failure

(2013) Torsten Doenst et al.   CIRCULATION RESEARCH

Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKC  Activation in Diabetes

(2012) A. Mima et al.   DIABETES

Diabetic cardiomyopathy

(2012) BR Goyal et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Overexpression of Vesicle-associated Membrane Protein (VAMP) 3, but Not VAMP2, Protects Glucose Transporter (GLUT) 4 Protein Translocation in anin VitroModel of Cardiac Insulin Resistance

(2012) Robert W. Schwenk et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy

(2012) Ronald M. Witteles et al.   JOURNAL OF CARDIAC FAILURE

Metabolic stress–induced activation of FoxO1 triggers diabetic cardiomyopathy in mice

(2012) Pavan K. Battiprolu et al.   JOURNAL OF CLINICAL INVESTIGATION

Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats

(2012) Dominik Linz et al.   Journal of Translational Medicine

Ischemia-Reperfusion Injury Leads to Distinct Temporal Cardiac Remodeling in Normal versus Diabetic Mice

(2012) Megumi Eguchi et al.   PLoS One

Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes

(2011) Susana Ravassa et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Sitagliptin Augments Protective Effects of GLP-1 against Advanced Glycation End Product Receptor Axis in Endothelial Cells

(2011) Y. Ishibashi et al.   HORMONE AND METABOLIC RESEARCH

Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states

(2011) Paola Moreno et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Contribution of organ blood flow, intrinsic tissue clearance and glycaemia to the regulation of glucose use in obese and type 2 diabetic rats: A PET study

(2011) L. Guiducci et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Murine Model of Dilated Cardiomyopathy

(2011) Arpita Kalla Vyas et al.   PLoS One

Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes

(2010) Theodore Mazzone   CIRCULATION

DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease

(2010) Philip A. Read et al.   Circulation-Cardiovascular Imaging

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control

(2010) P. Anagnostis et al.   DIABETES OBESITY & METABOLISM

GLP-1 (9–36) Amide Metabolite Suppression of Glucose Production in Isolated Mouse Hepatocytes

(2010) E. Tomas et al.   HORMONE AND METABOLIC RESEARCH

Myocardial Fatty Acid Metabolism in Health and Disease

(2010) Gary D. Lopaschuk et al.   PHYSIOLOGICAL REVIEWS

Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography

(2009) Charissa E van den Brom et al.   Cardiovascular Diabetology

GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

(2009) M. H. Noyan-Ashraf et al.   DIABETES

Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease

(2008) R. W. Schwenk et al.   CARDIOVASCULAR RESEARCH

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION

The PPAR trio: Regulators of myocardial energy metabolism in health and disease

(2008) Jose A. Madrazo et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Time Course of Alterations in Myocardial Glucose Utilization in the Zucker Diabetic Fatty Rat with Correlation to Gene Expression of Glucose Transporters: A Small-Animal PET Investigation

(2008) K. I. Shoghi et al.   JOURNAL OF NUCLEAR MEDICINE

GLP-1 (9-36) Amide, Cleavage Product of GLP-1 (7-36) Amide, Is a Glucoregulatory Peptide

(2008) Dariush Elahi et al.   Obesity